JP2021536433A5 - - Google Patents

Info

Publication number
JP2021536433A5
JP2021536433A5 JP2021509988A JP2021509988A JP2021536433A5 JP 2021536433 A5 JP2021536433 A5 JP 2021536433A5 JP 2021509988 A JP2021509988 A JP 2021509988A JP 2021509988 A JP2021509988 A JP 2021509988A JP 2021536433 A5 JP2021536433 A5 JP 2021536433A5
Authority
JP
Japan
Prior art keywords
alkyl
cooh
alkoxy
compound according
substituted
Prior art date
Application number
JP2021509988A
Other languages
English (en)
Japanese (ja)
Other versions
JP7405834B2 (ja
JPWO2020038435A5 (https=
JP2021536433A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/101985 external-priority patent/WO2020038435A1/en
Publication of JP2021536433A publication Critical patent/JP2021536433A/ja
Publication of JPWO2020038435A5 publication Critical patent/JPWO2020038435A5/ja
Publication of JP2021536433A5 publication Critical patent/JP2021536433A5/ja
Application granted granted Critical
Publication of JP7405834B2 publication Critical patent/JP7405834B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021509988A 2018-08-24 2019-08-22 ピリジニルメチレンピペリジン誘導体及びその使用 Active JP7405834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810969837.5 2018-08-24
CN201810969837 2018-08-24
PCT/CN2019/101985 WO2020038435A1 (en) 2018-08-24 2019-08-22 Pyridinylmethylenepiperidine derivatives and uses thereof

Publications (4)

Publication Number Publication Date
JP2021536433A JP2021536433A (ja) 2021-12-27
JPWO2020038435A5 JPWO2020038435A5 (https=) 2022-07-04
JP2021536433A5 true JP2021536433A5 (https=) 2022-07-04
JP7405834B2 JP7405834B2 (ja) 2023-12-26

Family

ID=68437065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021509988A Active JP7405834B2 (ja) 2018-08-24 2019-08-22 ピリジニルメチレンピペリジン誘導体及びその使用

Country Status (7)

Country Link
US (1) US11858910B2 (https=)
EP (1) EP3841096A4 (https=)
JP (1) JP7405834B2 (https=)
CN (1) CN110437205B (https=)
AU (1) AU2019323450B2 (https=)
CA (1) CA3107145A1 (https=)
WO (1) WO2020038435A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111187252B (zh) * 2019-11-22 2023-06-09 广东东阳光药业有限公司 吡啶酰基氮杂螺庚烷衍生物及其用途
CN111187251B (zh) * 2019-11-22 2023-06-09 广东东阳光药业有限公司 吡啶酰基哌啶衍生物及其用途
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
CN114685443B (zh) * 2020-12-29 2023-07-18 广东东阳光药业有限公司 吡啶烯基哌啶衍生物的盐及其用途
CN114685440B (zh) * 2020-12-29 2023-07-18 广东东阳光药业有限公司 吡啶烯基哌啶衍生物的盐及其用途
US20240083870A1 (en) * 2020-12-29 2024-03-14 Sunshine Lake Pharma Co., Ltd. Salts of pyridinylmethylenepiperidine derivatives and uses thereof
CN114685441B (zh) * 2020-12-29 2023-07-18 广东东阳光药业有限公司 吡啶烯基哌啶衍生物的盐及其用途
CN114685444B (zh) * 2020-12-29 2023-07-18 广东东阳光药业有限公司 吡啶烯基哌啶衍生物的盐及其用途
CN112939952A (zh) * 2021-02-02 2021-06-11 深圳市第二人民医院(深圳市转化医学研究院) 一种3-羟基查尔酮衍生物及其用途
CN112898276A (zh) * 2021-02-02 2021-06-04 深圳市第二人民医院(深圳市转化医学研究院) 一种查尔酮衍生物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA979961B (en) 1996-11-15 1999-05-05 Lilly Co Eli 5-HT1F agonists
US6133290A (en) 1998-07-31 2000-10-17 Eli Lilly And Company 5-HT1F agonists
US6777428B1 (en) 1999-02-10 2004-08-17 Eli Lilly And Company 5-HT1f agonist
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
MXPA05011223A (es) * 2003-04-18 2006-01-26 Lilly Co Eli Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas 5-htif.
UA82711C2 (en) * 2003-09-12 2008-05-12 Эли Лилли Энд Компани Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
DE602004008338T2 (de) 2003-12-17 2008-05-29 Eli Lilly And Co., Indianapolis Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten
DK2076508T3 (da) * 2006-10-18 2011-02-21 Pfizer Prod Inc Biaryl-ether-urinstof-forbindelser
CN101602708B (zh) * 2008-06-10 2012-11-21 江苏国华投资有限公司 芳烷醇哌啶衍生物及其在制备抗抑郁症药物中的应用
TW201028421A (en) 2009-01-15 2010-08-01 Abbott Lab Novel benzenesulfonamides as calcium channel blockers
GB201114448D0 (en) 2011-08-22 2011-10-05 Takeda Pharmaceutical Compounds and their use
MX2016016488A (es) 2014-08-27 2017-03-30 Hoffmann La Roche Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar).
GB201416513D0 (en) * 2014-09-18 2014-11-05 Astex Therapeutics Ltd And Cancer Res Technology Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2021536433A5 (https=)
RU2008150619A (ru) Производные пиразоло{3, 4-d}-пиримидина, применимые для лечения респираторных нарушений
AR057979A1 (es) PIRAZOLPIRIMIDINAS COMO INHIBIDORAS DE PROTEíNA QUINASA. COMPOSICIONES FARMACEUTICAS.
AR054127A1 (es) Imidazoquinolinas como inhibidores de quinasa de lipido
RU2011108281A (ru) Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
JP2007508305A5 (https=)
PE20160869A1 (es) Derivados novedosos de amino pirimidina
JP2011527667A5 (https=)
JP2017530199A5 (https=)
RU2012127334A (ru) Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения
AR076550A1 (es) Inhibidores de la janus tirosina kinasa (jak)
JP2012236838A5 (https=)
HRP20100670T1 (hr) Aril-supstituirani pirazol-amid spojevi korisni kao inhibitori kinaze
NO20014479L (no) Fremgangsmåte ved behandling av spiseforstyrrelser
RU2009123841A (ru) Замещенные производные 2,5-дигидро-3н-пиразоло[4,3-c]пиридазин-3-она, их получение и их применение в терапии
JP2013530176A5 (https=)
JP2008517983A5 (https=)
PT764166E (pt) Antagonistas de factor de libertacao de corticotropina
RU2009133794A (ru) Гербициды на основе замещенного n-оксида пиридина
JP2017531000A5 (https=)
JP2007516983A5 (https=)
CA2565852A1 (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
CA2088761A1 (en) Benzimidazole derivatives, process for their preparation and application
AR040278A1 (es) Ligandos del receptor de glucocorticoides para el tratamiento de trastornos metabolicos
JP2020505356A5 (https=)